Ignite Creation Date:
2025-12-24 @ 9:23 PM
Ignite Modification Date:
2026-03-12 @ 7:23 PM
Study NCT ID:
NCT03254732
Status:
TERMINATED
Last Update Posted:
2022-04-27
First Post:
2016-12-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study ADI-PEG 20 Plus Pembrolizumab in Advanced Solid Cancers
Sponsor:
Polaris Group
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
POLARIS2016-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None